XML 52 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation, Summary of Significant Accounting Policies and Change in Accounting Principles (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Restricted Cash And Cash Equivalents
Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:
December 31,
20222021
Collateral for letters of credit for facility leases (1)
$2,269 $3,769 
Collateral with financial institutions (2)
10,912 11,662 
Claims processing services (3)
13,777 73,226 
Other— 
Total restricted cash and restricted investments$26,958 $88,662 
Current restricted cash14,492 75,685 
Total current restricted cash and restricted investments$14,492 $75,685 
Non-current restricted cash12,466 12,977 
Total non-current restricted cash and restricted investments$12,466 $12,977 
————————
(1)Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note 12 for further discussion of our lease commitments.
(2)Represents collateral held with financial institutions for risk-sharing and other arrangements which are held in a FDIC participating bank account. See Note 18 for discussion of fair value measurement and Note 11 for discussion of our risk-sharing arrangements.
(3)Represents cash held by the Company related to claims processing services on behalf of partners. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):
December 31,
20222021
Cash and cash equivalents$188,200 $266,280 
Restricted cash and restricted investments26,958 88,662 
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows (1)
$215,158 $354,942 
————————
(1)As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for year ended December 31, 2021. See Note 5.
Schedule of Cash And Cash Equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):
December 31,
20222021
Cash and cash equivalents$188,200 $266,280 
Restricted cash and restricted investments26,958 88,662 
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows (1)
$215,158 $354,942 
————————
(1)As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for year ended December 31, 2021. See Note 5.
Summary of property and equipment The following summarizes the estimated useful lives by asset classification:
Computer hardware3 years
Computer software1 year
Furniture and equipment
3 - 7 years
Internal-use software development costs5 years
Leasehold improvementsShorter of useful life or remaining lease term
The following summarizes our property and equipment (in thousands):
December 31,
20222021
Computer hardware$30,092 $21,970 
Furniture and equipment4,214 3,581 
Internal-use software development costs189,119 159,587 
Leasehold improvements14,926 15,325 
Total property and equipment238,351 200,463 
Accumulated depreciation and amortization expenses(150,477)(119,098)
Total property and equipment, net$87,874 $81,365 
Schedule of Intangible Assets
The following summarizes the estimated useful lives by asset classification:
Corporate trade name
10 - 20 years
Customer relationships
11 - 25 years
Technology5 years
Provider network contracts
3 - 5 years
Details of our intangible assets (in thousands, except weighted-average useful lives) are presented below:

December 31, 2022December 31, 2021
  Weighted- Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying ValueWeighted- Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying Value
Corporate trade name12.7$43,600 $11,726 $31,874 12.4$25,800 $7,693 $18,107 
Customer relationships15.8465,019 92,760 372,259 14.9311,019 72,697 238,322 
Technology2.7111,822 80,255 31,567 2.087,922 73,378 14,544 
Below market lease, net0.31,218 1,151 67 1.31,218 950 268 
Provider network contracts1.318,851 11,834 7,017 2.216,417 7,874 8,543 
Total intangible assets, net$640,510 $197,726 $442,784 $442,376 $162,592 $279,784